Proven Healthcare and Life Sciences Market Insights for Financial Services

Financial firms trust Komodo’s real-world data to support high-value investments, de-risk portfolio decisions, and gain insight into healthcare and Life Sciences markets.

Talk to an Expert

See How Financial Firms Make Confident Decisions With Komodo

Conduct Market Analysis and Opportunity Sizing

Fragmented data makes it difficult to size high-growth opportunities. Komodo’s Healthcare Map® combines real-world patient journeys with Komodo Drug Projections to provide a clearer view of disease prevalence, treatment adoption, and market penetration — enabling more confident, data-backed decisions.

Talk to an Expert

Optimize Portfolio Performance

Tracking drug performance and market dynamics across sources is often inconsistent. Komodo’s dashboards and analytics help investors monitor portfolio assets, identify meaningful trends, and understand shifts in demand and access over time.

Talk to an Expert

Meet Marmot: Earlier Signals for Healthcare Investing

Marmot™ is Komodo’s AI-powered analysis experience for healthcare investors — built on the Healthcare Map to surface early demand signals, accelerate conviction, and move before consensus. 

Talk to an Expert

Track Specialty Drug Markets

Limited payer and provider visibility often restricts insight into specialty drug markets. Komodo’s comprehensive datasets capture real-world prescribing and utilization patterns, enabling investors to track adoption trends and forecast demand in complex specialty segments.

Talk to an Expert

Overcome Payer Bias for Accurate Market Forecasting

Fragmented claims data can skew market projections. Komodo’s proprietary provider mix calculation reduces payer bias, delivering more accurate and defensible market forecasts — particularly in specialty drug markets.

Talk to an Expert

Link Lab, Genomics, and EHR Data for Rare Disease Market Sizing

Rare disease analysis requires more than claims data alone. Komodo integrates lab, genomics, and EHR data to help investors understand patient populations, treatment pathways, and unmet need — supporting more confident market assessments.

Talk to an Expert

See How Komodo Powers Smarter Healthcare and Life Sciences Investments

Unlock data-driven insights to optimize portfolio decisions, track specialty drug markets, and stay ahead of investment trends.

Talk to an Expert